Skip to content

Early closure of stoma (temporary ileostomy )in comparison to standard procedure late closure of stoma after rectal cancer Surgery

Early versus delayed stoma reversal after rectal cancer resections â?? A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048069
Enrollment
88
Registered
2022-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C20- Malignant neoplasm of rectum

Interventions

Intervention1: Early stoma closure: Arm A Early stoma closure between day 7 â?? day 28 of primary surgery Control Intervention1: delayed stoma closure: Arm B Standard delayed stoma closure- according

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: â??Age group 18 to70 years â??Able to give informed consent â??Rectal adenocarcinoma proven by biopsy â??Undergoing primary surgical procedure as low anterior resection with stapled anastomosis with diversion loop ileostomy â??No anastomotic leak documented at the time of randomization

Exclusion criteria

Exclusion criteria: â??Primary surgical procedure Inter sphincteric resection low coloanal hand sewn anastomosis colostomy performed as diversion â??Patients having diversion stoma in place done for obstruction before initiating neoadjuvant treatment â??Diversion stomas other than loop ileostomy â??Uncontrolled comorbidites or ASA3 patients at high risk for developing complications as assessed by the multidisciplinary team

Design outcomes

Primary

MeasureTime frame
Stoma free rates at 1 year after initial surgeryTimepoint: 1 years

Secondary

MeasureTime frame
Complication rates reported on the Clavien-Dindo scale. A complication of Grade IIIA or higher will be considered as major morbidity at 90 days after surgery. â??Completion or Compliance to adjuvant chemotherapy â??QoL EORTC QLQ C 30 assessment at 6 months and 1 year of primary surgery â??Disease-free survival DFSTimepoint: 2 years

Countries

India

Contacts

Public ContactDr Avanish Saklani

Tata Memorial Hospital

asaklani@hotmail.com7400319886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026